BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
8.48
-0.02 (-0.24%)
At close: Mar 6, 2026, 4:00 PM EST
8.60
+0.12 (1.42%)
After-hours: Mar 6, 2026, 7:37 PM EST

BioCryst Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
263.86-88.88-226.54-247.12-184.06
Depreciation & Amortization
1.391.251.661.440.78
Stock-Based Compensation
85.0765.4155.6244.734.64
Other Adjustments
53.9557.48106.5398.07-1.64
Change in Receivables
-36.81-22.7-6.1-21.47-20.82
Changes in Inventories
-1.64-4.16-1.45-12.42-8.77
Changes in Accounts Payable
57.814.7812.53-22.3639.41
Changes in Accrued Expenses
----4.17
Changes in Unearned Revenue
---1.23-0.111.28
Changes in Other Operating Activities
-76.26-75.2-36.16-2.58-7.16
Operating Cash Flow
347.37-52.02-95.14-161.85-142.16
Capital Expenditures
-2.47-1.12-2.17-1.25-2.39
Purchases of Investments
-262.24-266.76-514.41-244.28-10.01
Proceeds from Sale of Investments
256.65320.48385.08117.428.2
Proceeds from Business Divestments
-6.18----
Other Investing Activities
0.55----
Investing Cash Flow
-13.6952.59-131.5-128.2415.8
Long-Term Debt Issued
--30073.07293.87
Long-Term Debt Repaid
-324.87-1.7-241.62--
Net Long-Term Debt Issued (Repaid)
-324.87-1.758.3873.07293.87
Issuance of Common Stock
9.173.488.6814.9665.79
Repurchase of Common Stock
-8.85-7.54-2.17--
Net Common Stock Issued (Repurchased)
0.33-4.066.5114.9665.79
Other Financing Activities
-34.23-7.54-34.58--
Financing Cash Flow
-349.93-5.7632.4988.03359.67
Effect of Exchange Rate Changes on Cash and Cash Equivalents
1.27-0.940.360.570.07
Net Cash Flow
-14.99-6.12-193.79-201.5233.39
Free Cash Flow
344.9-53.14-97.31-163.1-144.54
FCF Margin
39.42%-11.79%-29.36%-60.22%-91.97%
Free Cash Flow Per Share
1.58-0.26-0.51-0.88-0.81
Levered Free Cash Flow
-82.18-155.05-194.98-211.33137.15
Unlevered Free Cash Flow
315.32-67.06-130.67-187.38-152.59
Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q